Summary: Spliceosome machinery mutations are common early mutations in myeloid malignancies; however. effective targeted therapies against them are still lacking. In the current study. we used an in vitro high-throughput drug screen among four different isogenic cell lines and identified RKI-1447. https://www.foldlyers.shop/product-category/deep-fryers/